Overview
Documents
Training
An accurate PCR NAAT test for group B strep detection
With performance you can trust, the Panther Fusion® GBS assay transforms your laboratory workflow and expands the molecular menu on the Panther Fusion® system. The assay detects the gram-positive bacterium Streptococcus agalactiae (GBS) from antepartum women, which demonstrated 100% sensitivity.1
Using a NAAT increases the opportunity to identify additional mothers
The Panther Fusion® GBS PCR nucleic acid amplification test (NAAT) detected 31% more positives than culture.2 All women should be screened for GBS between 36 0/7 and 37 6/7 weeks per the ACOG Guidelines. Emerging research suggests that PCR NAATs are highly sensitive and should be considered the preferred method for GBS screening in the prenatal period.2
The Panther Fusion GBS assay design1
Detects Group B Streptococcus DNA from antepartum women, following an 18–24-hour incubation in selective enrichment broth culture of Lim Broth or Carrot Broth.
Features dual-target detection of the Cfb and SIP genes, showing 100% clinical sensitivity and 96.5% specificity in a clinical trial.
Assay Specifications
Screening window:
Antepartum women
Specimen type:
Single vaginal-rectal swab3
Media Type:
Liquid Stuart or Amies without charcoal
Enrichment broth:
Lim Broth or Carrot Broth
Turnaround time (TAT):
Quick TAT, <2.4 hours4
Saving Lives Through Accurate Detection: An Overview of GBS Screening Guidelines During Pregnancy
Panther Fusion® GBS Assay: Testing the Benefits of NAATs versus Culture for Group B Strep Screening
How much time and money could you save?
The Panther Fusion GBS assay run on the Panther Fusion system offers:
- Full automation
- High throughput
- Ready-to-use reagents with 30-60 day on board stability, eliminating reagent prep and waste1
- A non-batch workflow
Consolidate your group B strep testing on the Panther Fusion system with other Aptima® and Panther Fusion® assays for women's health, virology, respiratory and sexually transmitted infections.
